🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/05/2000 | 0,2767 USD |
| 01/03/2000 | 0,2767 USD |
| 01/12/1999 | 0,2767 USD |
| 01/09/1999 | 0,2767 USD |
| 02/06/1999 | 0,2576 USD |
| 03/03/1999 | 0,2576 USD |
| 02/12/1998 | 0,2576 USD |
| 02/09/1998 | 0,2576 USD |
| 03/06/1998 | 0,2147 USD |
| 04/03/1998 | 0,2147 USD |
| 03/12/1997 | 0,2147 USD |
| 03/09/1997 | 0,2147 USD |
| 05/06/1997 | 0,2004 USD |
| 05/03/1997 | 0,2004 USD |
| 05/12/1996 | 0,1908 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/12/1971 | 1,61 | 1,63 | 1,61 | 1,63 | +0,92% | 1,03% | 2.988.058 |
| 07/12/1971 | 1,61 | 1,63 | 1,60 | 1,61 | +0,11% | 1,65% | 860.198 |
| 06/12/1971 | 1,60 | 1,64 | 1,60 | 1,61 | +0,41% | 2,48% | 1.448.755 |
| 03/12/1971 | 1,59 | 1,63 | 1,58 | 1,60 | +0,94% | 3,24% | 1.214.842 |
| 02/12/1971 | 1,57 | 1,60 | 1,56 | 1,59 | +1,48% | 2,33% | 1.358.208 |
| 01/12/1971 | 1,56 | 1,57 | 1,55 | 1,57 | +0,21% | 1,06% | 1.011.110 |
| 30/11/1971 | 1,54 | 1,56 | 1,52 | 1,56 | +1,62% | 2,48% | 980.928 |
| 29/11/1971 | 1,51 | 1,54 | 1,51 | 1,54 | +1,98% | 1,75% | 1.290.298 |
| 26/11/1971 | 1,47 | 1,51 | 1,47 | 1,51 | +2,47% | 2,24% | 762.106 |
| 24/11/1971 | 1,47 | 1,48 | 1,47 | 1,47 | -0,22% | 0,67% | 943.200 |
| 23/11/1971 | 1,49 | 1,49 | 1,45 | 1,47 | -1,11% | 2,88% | 988.474 |
| 22/11/1971 | 1,53 | 1,53 | 1,48 | 1,49 | -2,39% | 2,82% | 875.290 |
| 19/11/1971 | 1,53 | 1,53 | 1,50 | 1,53 | +0,00% | 1,73% | 724.378 |
| 18/11/1971 | 1,52 | 1,55 | 1,52 | 1,53 | +0,66% | 2,08% | 830.016 |
| 17/11/1971 | 1,48 | 1,52 | 1,46 | 1,52 | +2,46% | 3,69% | 1.335.571 |
| 16/11/1971 | 1,49 | 1,49 | 1,47 | 1,48 | -0,56% | 1,33% | 905.472 |
| 15/11/1971 | 1,48 | 1,50 | 1,47 | 1,49 | +0,79% | 2,13% | 671.558 |
| 12/11/1971 | 1,50 | 1,50 | 1,46 | 1,48 | -1,98% | 2,65% | 913.018 |
| 11/11/1971 | 1,56 | 1,56 | 1,50 | 1,51 | -3,60% | 3,93% | 2.256.134 |
| 10/11/1971 | 1,55 | 1,58 | 1,54 | 1,56 | +0,96% | 2,03% | 882.835 |
| 09/11/1971 | 1,54 | 1,55 | 1,54 | 1,55 | +1,30% | 0,97% | 392.371 |
| 08/11/1971 | 1,53 | 1,54 | 1,53 | 1,53 | -0,11% | 0,76% | 309.370 |
| 05/11/1971 | 1,52 | 1,53 | 1,52 | 1,53 | +0,88% | 0,88% | 445.190 |
| 04/11/1971 | 1,52 | 1,54 | 1,52 | 1,52 | +0,11% | 1,31% | 1.116.749 |
| 03/11/1971 | 1,50 | 1,52 | 1,50 | 1,52 | +1,22% | 0,88% | 1.048.838 |
| 02/11/1971 | 1,50 | 1,50 | 1,48 | 1,50 | -0,22% | 1,11% | 1.667.578 |
| 01/11/1971 | 1,52 | 1,52 | 1,50 | 1,50 | -1,41% | 1,41% | 950.746 |
| 29/10/1971 | 1,49 | 1,52 | 1,49 | 1,52 | +2,34% | 1,89% | 1.199.750 |
| 28/10/1971 | 1,46 | 1,50 | 1,46 | 1,49 | +1,58% | 2,94% | 1.094.112 |
| 27/10/1971 | 1,46 | 1,47 | 1,46 | 1,46 | +0,45% | 0,91% | 520.646 |